Revisiting the standard blueprint for biomarker development to address emerging cancer early detection technologies
Novel liquid biopsy technologies are creating a watershed moment in cancer early
detection. Evidence supporting population screening is nascent, but a rush to market the …
detection. Evidence supporting population screening is nascent, but a rush to market the …
Revisiting the standard blueprint for biomarker development to address emerging cancer early detection technologies
R Etzioni, R Gulati, C Patriotis… - Journal of the …, 2024 - pubmed.ncbi.nlm.nih.gov
Novel liquid biopsy technologies are creating a watershed moment in cancer early
detection. Evidence supporting population screening is nascent, but a rush to market the …
detection. Evidence supporting population screening is nascent, but a rush to market the …
Revisiting the standard blueprint for biomarker development to address emerging cancer early detection technologies
R Etzioni, R Gulati, C Patriotis, C Rutter… - JNCI: Journal of the …, 2023 - academic.oup.com
Novel liquid biopsy technologies are creating a watershed moment in cancer early
detection. Evidence supporting population screening is nascent, but a rush to market the …
detection. Evidence supporting population screening is nascent, but a rush to market the …
Revisiting the Standard Blueprint for Biomarker Development to Address Emerging Cancer Early Detection Technologies.
R Etzioni, R Gulati, C Patriotis, C Rutter… - Journal of the …, 2023 - europepmc.org
Novel liquid biopsy technologies are creating a watershed moment in cancer early
detection. While evidence supporting population screening is nascent, a rush to market the …
detection. While evidence supporting population screening is nascent, a rush to market the …